Table 4.
The PerAF methods applied in neurogenic diseases.
| PerAF method applied in neurogenic diseases | ||||
|---|---|---|---|---|
| References | Disease | Brain areas | ||
| PerAF increased | PerAF decreased | |||
| Neurogenic diseases | Wang et al. (20) | ET-1 | B1-4: vermis VIII, B1-3: LCL VIII, B1-4: LPG |
B5: vermis VIII, B4-5: LCL VIII, B5: LPG |
| Zeng et al. (21) | Sleep Deprivation | BVC, BSC | BDPC, BCPL | |
| Yu et al. (19) | MCID | lLPHGs, TG | N/A | |
ET-1, Type I epilepsy; B1-4, frequency band B1, B2, B3, B4; B1-3, frequency band B1, B2, B3; B5, frequency band 5; B4-5, frequency band B4, B5; LCL VIII, left cerebellar lobule VIII; LPG, left precentral gyrus; BVC, bilateral vision cortex; BSC, bilateral sensorimotor cortex; LPG, left para-hippocampus gyrus; MCID, mild cognitive impairment with depression symptom; TG, temporal gyrus; BDPC, bilateral dorsolateral prefrontal cortex; BCPL, bilateral cerebellum posterior lobe. PerAF, percent amplitude of fluctuation.